Search Results
| نشرة الممارس الصحي | نشرة معلومات المريض بالعربية | نشرة معلومات المريض بالانجليزية | صور الدواء | بيانات الدواء |
|---|
Properties:
An antibiotic with powerful antibacterial activity against a number of
gram - positive organisms, staphylococci including t h e strains resistant to
penicillin, besides pronounced antibacterial activity against the majority of
organisms responsible for skin infections
Indications :
Uciderm is used in treatment of skin infections caused by staphylococci,
streptococci , propionibacterium acnes, cornebacterium minutissimum and
other Uciderm sensitive organisms.
Main Uses:
Acne vulgaris, impetigo , boils , carbuncles, hidradenitis , infected wounds ,
folliculitis , sycosis barbae, erylhrasma and paronychia .
Generally Uciderm is very well tolerated and in rare cases, signs of
hypersensitivity reactions can occur .
Uciderm should be applied 2 ·3 times daily to the affected area for a period of 7
days, except of acne where therapy should be extended for a longer period.
Generally Uciderm is very well tolerated and in rare cases, signs of
hypersensitivity reactions can occur .
Keep at room temperature not exceeding 25"C •
Composition :
Each gram contains: Fusidic Acid 20 mg in a cream base
Philadelphia Pharmaceuticals
10. St. King Abdullah II Industrial City / Amman – Jordan
P.O.Box : 276 – Amman 11512 Jordan
Tel : + 962 6 402 9181
Fax : + 962 6 402 9182
الخواص:
اليوسيديرم مضاد حيوي قوي ذو فعالية قوية للغاية ضد عدد من البكتيريا الموجبة الغرام، البكتيريا العنقودية بما في ذلك السلالات المقاومة للبنسلين، بالاضافة للمقدرة العلاجية لليوسيديرم ضد البكتيريا التي تصيب الجلد.
الاستعمالات:
يستعمل يوسيديرم كريم في معالجة الالتهابات الجلدية الناتجة عن الإصابة بالبكتيريا العنقودية، البكتيريا السبحية، بكتيريا بربيوني اكنس ( المسببة لحب الشباب)، بكتيريا كورين مينوتيسموم والجراثيم الأخرى الحساسة لليوسيديرم
أهم الستعمالات الرئيسية:
حب الشباب والحصف والدمامل والدملات والتهاب الغدة العرقية (تحت الابط) والجروح الملتهبة والتهاب منابت الشعر وقوباء اللحية واحمرار الارضاع والتهاب حتر الاصبع
بشكل عام لا يحدث مع يوسيديرم أعراض جانبية واحتمال حدوث تفاعلات حساسية تكون ناددرة للغاية
تدهن الأماكن المصابة بكريم يوسيديرم من 2 - 3 مرات يوميا ولمدة 7 أيام ، ما عدا حب الشباب حيث تتطلب المعالجة مدة أطول من ذلك.
بشكل عام لا يحدث مع يوسيديرم أعراض جانبية واحتمال حدوث تفاعلات حساسية تكون ناددرة للغاية
يحفظ يوسيديرم بدرجة حرارة أقل من 25 م
كل غرام يوسيديرم يحتوي هلى حامض الفوسديك 20 ملغم في قاعدة كريم.
انبوب 15 غرام
شركة فیلادلفیا لصناعة الأدویة
شارع ۱۰ مدینة الملك عبدلله الثاني الصناعیة - عمان / الاردن
ص.ب ۲۷٦ – عمان ( ۱۱٥۱۲ ) الأردن
الھاتف : 96264029181+
فاكس : 96264029182+
Indicated either alone or in combination with systemic therapy, in the treatment of primary and secondary skin infections caused by sensitive strains of Staphylococcus aureus, Streptococcus spp and Corynebacterium minutissimum. Primary skin infections that may be expected to respond to treatment with Fusidic acid applied topically include: impetigo contagiosa, superficial folliculitis, sycosis barbae, paronychia and erythrasma; also such secondary skin infections as infected eczematoid dermatitis, infected contact dermatitis and infected cuts/abrasions.
Adults and Children: Uncovered lesions - apply gently two to three times daily. Covered lesions - less frequent applications may be adequate
Bacterial resistance among staphylococcus aureus has been reported to occur with the use of topical Uciderm Cream, as with all antibiotics, extended or recurrent use may increase the risk of developing antibiotic resistance. Extended or recurrent use may increase the risk of developing contact sensitization
No interaction studies have been performed. Interactions with systemically administered medicinal products are considered minimal as the systemic absorption of topical Uciderm Cream is negligible
Fertility There are no clinical studies with topical Uciderm Cream regarding fertility. No effects in women of childbearing potential are anticipated, since systemic exposure following topically applied fusidic acid/sodium fusidate is negligible. Pregnancy No effects during pregnancy are anticipated, since systemic exposure to topically applied Fusidic acid/sodium fusidate is negligible. Topical Uciderm Cream can be used during pregnancy. Breast-feeding No effects on the breastfed new-born/infant are anticipated since the systemic exposure of topically applied Fusidic acid/sodium fusidate to the breast-feeding woman is negligible. Topical Uciderm Cream can be used during breast-feeding but it is recommended to avoid applying topical Uciderm Cream on the breast.
Uciderm Cream administered topically has no or negligible influence on the ability to drive or to use machines.
The estimation of the frequency of undesirable effects is based on a pooled analysis of data from clinical trials and from spontaneous reporting.
The estimation of the frequency of undesirable effects is based on a pooled analysis of data from clinical trials and from spontaneous reporting.
Fusidic acid is a potent antibacterial agent. Fusidic acid and its salts show fat and water solubility and strong surface activity and exhibit unusual ability to penetrate intact skin. Concentrations of 0.03 - 0.12 mcg Fusidic acid per ml inhibit nearly all strains of Staphylococcus aureus. Topical application of Fusidic acid is also effective against streptococci, Corynebacterium, Neisseria and certain clostridia
In Vitro studies show that Fusidic acid can penetrate intact human skin. The degree of penetration depends on factors such as the duration of exposure to Fusidic acid and the condition of the skin. Fusidic acid is excreted mainly in the bile with little excreted in the urine
There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC
Cetostearyl Alcohol. White Soft Paraffin. Polyoxyl 40 stearate. Liquid paraffin. Isopropyl Myristate. Glycerol. Methyl Hydroxybenzoate. Propyl Hydroxybenzoate. Water Purified.
Not applicable
Store below 30° C.
Aluminum tubes of 15 gm.
NA
